Literature DB >> 15015887

Guidance and control of percutaneous treatments with contrast-enhanced ultrasound.

L Solbiati1, T Ierace, M Tonolini, L Cova.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 15015887     DOI： 10.1007/s00330-003-0013-1

Source DB:  PubMed          Journal:  Eur Radiol        ISSN： 0938-7994            Impact factor:   5.315


× No keyword cloud information.
  6 in total

Review 1.  The role of contrast-enhanced ultrasound in the detection of focal liver leasions.

Authors:  L Solbiati; M Tonolini; L Cova; S N Goldberg
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

2.  Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year.

Authors:  T de Baere; D Elias; C Dromain; M G Din; V Kuoch; M Ducreux; V Boige; N Lassau; V Marteau; P Lasser; A Roche
Journal:  AJR Am J Roentgenol       Date:  2000-12       Impact factor: 3.959

Review 3.  Minimally invasive treatment of malignant hepatic tumors: at the threshold of a major breakthrough.

Authors:  G D Dodd; M C Soulen; R A Kane; T Livraghi; W R Lees; Y Yamashita; A R Gillams; O I Karahan; H Rhim
Journal:  Radiographics       Date:  2000 Jan-Feb       Impact factor: 5.333

4.  Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT.

Authors:  S Chopra; G D Dodd; K N Chintapalli; J R Leyendecker; O I Karahan; H Rhim
Journal:  AJR Am J Roentgenol       Date:  2001-08       Impact factor: 3.959

Review 5.  Essential techniques for successful radio-frequency thermal ablation of malignant hepatic tumors.

Authors:  H Rhim; S N Goldberg; G D Dodd; L Solbiati; H K Lim; M Tonolini; O K Cho
Journal:  Radiographics       Date:  2001-10       Impact factor: 5.333

6.  Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic-pathologic correlation.

Authors:  S N Goldberg; G S Gazelle; C C Compton; P R Mueller; K K Tanabe
Journal:  Cancer       Date:  2000-06-01       Impact factor: 6.860
  6 in total
  5 in total

1.  Intraoperative magnetic resonance imaging for ablation of hepatic tumors.

Authors:  R C G Martin; S Husheck; C R Scoggins; K M McMasters
Journal:  Surg Endosc       Date:  2006-08-01       Impact factor: 4.584

2.  Can contrast-enhanced ultrasound evaluate the severity of acute pancreatitis?

Authors:  Qiang Lu; Yue Zhong; Xiao-rong Wen; Zong-wen Huang; Yu-ting Fan; Qing Xia; Yan Luo
Journal:  Dig Dis Sci       Date:  2010-11-28       Impact factor: 3.199

3.  Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment.

Authors:  Wei Yang; Kun Yan; S Nahum Goldberg; Muneeb Ahmed; Jung-Chieh Lee; Wei Wu; Zhong-Yi Zhang; Song Wang; Min-Hua Chen
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

4.  Role of contrast-enhanced ultrasonography in percutaneous radiofrequency ablation of liver metastases and efficacy evaluation.

Authors:  Jie Wu; Wei Yang; Shanshan Yin; Jinyu Wu; Wei Wu; Kun Yan; Minhua Chen
Journal:  Chin J Cancer Res       Date:  2013-04       Impact factor: 5.087

Review 5.  Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions.

Authors:  Jae Young Jang; Moon Young Kim; Soung Won Jeong; Tae Yeob Kim; Seung Up Kim; Sae Hwan Lee; Ki Tae Suk; Soo Young Park; Hyun Young Woo; Sang Gyune Kim; Jeong Heo; Soon Koo Baik; Hong Soo Kim; Won Young Tak
Journal:  Clin Mol Hepatol       Date:  2013-03-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.